SAMHSA In-Person Physical Evaluation Flexibility Extension Guidance For Opioid Treatment Programs

On June 28, 2022, the U.S. Substance Abuse and Mental Health Services Administration (SAMHSA) published this guidance for in-person physical evaluation flexibility extension for opioid treatment programs. In April 2020, during the coronavirus disease 2019 (COVID-19) Public Health Emergency, SAMHSA issued an exemption to Opioid Treatment Programs (OTP) from the requirement to perform an in-person physical evaluation (under 42 C.F.R. § 8.12(f)(2)) forany patient who will be treated by the OTP with buprenorphine if a program physician, primary carephysician, or an authorized healthcare professional under the supervision of a program physician,determines . . .